Article

Testicular cancer treatment impairs semen quality

Philadelphia--Treatment for testicular cancer caused the rates of severe oligozoospermia and azoospermia to rise from 7% to 27% and 0% to 12%, respectively, in a study that suggests a need for sperm banking in men treated for the disease.

Related Videos
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Why a personalized approach is key to prolapse and OAB management
Anna Myers, CNP, answers a question during a Zoom video interview
Anna Myers, CNP, on the overlap between urological and gynecological conditions
Sarah Ponce discusses pelvic and vulvovaginal pain among medical trainees
Sarah Ponce discusses pelvic and vulvovaginal pain among medical trainees
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Expert offers advice on starting a sexual wellness/aesthetics practice
Patient talking with doctor | Image Credit: © bongkarn - stock.adobe.com
Expert discusses pelvic pain and vesicovaginal fistula
Shaya Taghechian, MD, answers a question during a video interview
Dr. Taghechian on her women’s sexual health practice
doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Expert urges patient education on vaginal estrogen products
Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
Dr. Syan shares her thoughts on SUFU 2024
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
BMI may increase complications for prolapse surgery
Cassandra K. Kisby, MD, MS, answers a question during a Zoom video interview
Dr. Kisby on obesity in patients undergoing prolapse surgery
Related Content
FDA updates in urology: March 2025
April 1st 2025

FDA updates in urology: March 2025

Hannah Clarke
A recap of the FDA submissions and regulatory decisions in urology from March 2025.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
March 25th 2025

Expert discusses unique mechanism of action of UTI treatment gepotidacin

Ryan Haumschild, PharmD, MS, MBA, CPEL
"I think [gepotidacin] gives a different side effect profile available to the clinicians, and I think for patients as well, it provides a better, more durable option over time," says Ryan Haumschild, PharmD, MS, MBA, CPEL.
Dr. Malik evaluates quality of Reddit content on recurrent UTIs
March 17th 2022

Dr. Malik evaluates quality of Reddit content on recurrent UTIs

Urology Times staff
“I think we as urologists have to be proactive in providing information to our patients so that they avoid financial harm and potentially bodily harm from this sort of misinformation,” says Rena D. Malik, MD.
Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome
March 11th 2025

Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome

Hannah Clarke
"The findings from this study will help us understand sunobinop’s potential as a possible new treatment option for this chronic disorder,” said Craig Landau, MD.
Efficacy of sildenafil cream for FSAD maintained across patient subgroups
December 16th 2024

Efficacy of sildenafil cream for FSAD maintained across patient subgroups

Hannah Clarke
Age, race, and hormonal contraceptive use did not significantly impact the efficacy of sildenafil cream, 3.6%, in female sexual arousal disorder.
© 2025 MJH Life Sciences

All rights reserved.